Exact Mass: 407.11692860000005

Exact Mass Matches: 407.11692860000005

Found 55 metabolites which its exact mass value is equals to given mass value 407.11692860000005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cefzil

Cefprozil hydrate

C18H21N3O6S (407.11510060000006)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Sitagliptin

(2R)-4-oxo-4-[3-(TRIFLUOROMETHYL)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine

C16H15F6N5O (407.11807319999997)


Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. This enzyme-inhibiting drug is to be used either alone or in combination with metformin or a thiazolidinedione for control of type 2 diabetes mellitus. The drug works to competitively inhibit a protein/enzyme, dipeptidyl peptidase 4 (DPP-4), that results in an increased amount of active incretins (GLP-1 and GIP), reduced amount of release of glucagon (diminishes its release) and increased release of insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

rac-Sitagliptin

4-oxo-4-(3-(Trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine

C16H15F6N5O (407.11807319999997)


   

8'-(Pyridin-2-ylmethoxy)spiro[2,4-dioxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene-3,4'-naphthalene]-1'-one

5-[(pyridin-2-yl)methoxy]-4H-2,4-dioxaspiro[naphthalene-1,3-tricyclo[7.3.1.0^{5,13}]tridecane]-1(12),5,7,9(13),10-pentaen-4-one

C26H17NO4 (407.11575220000003)


   

ZINC18188319

ZINC18188319

C17H21N5O3S2 (407.10857560000005)


   

4,8-dimethoxy-furo[2,3-b]quinolin-7-yl beta-D-glucopyranoside|Glucohaplin|glucohapline|glycohaplopine|O-beta-D-glucopyranosyl-haplopine

4,8-dimethoxy-furo[2,3-b]quinolin-7-yl beta-D-glucopyranoside|Glucohaplin|glucohapline|glycohaplopine|O-beta-D-glucopyranosyl-haplopine

C19H21NO9 (407.1216256)


   

Sitagliptin

Sitagliptin

C16H15F6N5O (407.11807319999997)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 84 CONFIDENCE standard compound; INTERNAL_ID 2257 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2903

   

PharmaGSID_48506

PharmaGSID_48506

C19H22ClN3O3S (407.10703320000005)


CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4364; ORIGINAL_PRECURSOR_SCAN_NO 4361 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4388; ORIGINAL_PRECURSOR_SCAN_NO 4386 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4368; ORIGINAL_PRECURSOR_SCAN_NO 4366 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4379; ORIGINAL_PRECURSOR_SCAN_NO 4377 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4383; ORIGINAL_PRECURSOR_SCAN_NO 4381 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9274; ORIGINAL_PRECURSOR_SCAN_NO 9269 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9271; ORIGINAL_PRECURSOR_SCAN_NO 9270 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9273; ORIGINAL_PRECURSOR_SCAN_NO 9271 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9287; ORIGINAL_PRECURSOR_SCAN_NO 9284 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9304; ORIGINAL_PRECURSOR_SCAN_NO 9303 CONFIDENCE standard compound; INTERNAL_ID 1004; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9292; ORIGINAL_PRECURSOR_SCAN_NO 9291

   

Cys Asp Gly Asn

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C13H21N5O8S (407.11107860000004)


   

Cys Asp Asn Gly

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Cys Gly Asp Asn

(3S)-3-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Cys Gly Asn Asp

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanamido]butanedioic acid

C13H21N5O8S (407.11107860000004)


   

Cys Asn Asp Gly

(3S)-3-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C13H21N5O8S (407.11107860000004)


   

Cys Asn Gly Asp

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetamido}butanedioic acid

C13H21N5O8S (407.11107860000004)


   

Asp Cys Gly Asn

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanoic acid

C13H21N5O8S (407.11107860000004)


   

Asp Cys Asn Gly

(3S)-3-amino-3-{[(1R)-1-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Asp Gly Cys Asn

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C13H21N5O8S (407.11107860000004)


   

Asp Gly Asn Cys

(3S)-3-amino-3-[({[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C13H21N5O8S (407.11107860000004)


   

Asp Asn Cys Gly

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Asp Asn Gly Cys

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Gly Cys Asp Asn

(3S)-3-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Gly Cys Asn Asp

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carbamoylpropanamido]butanedioic acid

C13H21N5O8S (407.11107860000004)


   

Gly Asp Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C13H21N5O8S (407.11107860000004)


   

Gly Asp Asn Cys

(3S)-3-(2-aminoacetamido)-3-{[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Gly Asn Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-sulfanylpropanamido]butanedioic acid

C13H21N5O8S (407.11107860000004)


   

Gly Asn Asp Cys

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Asn Cys Asp Gly

(3S)-3-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C13H21N5O8S (407.11107860000004)


   

Asn Cys Gly Asp

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetamido}butanedioic acid

C13H21N5O8S (407.11107860000004)


   

Asn Asp Cys Gly

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Asn Asp Gly Cys

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C13H21N5O8S (407.11107860000004)


   

Asn Gly Cys Asp

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanamido]butanedioic acid

C13H21N5O8S (407.11107860000004)


   

Asn Gly Asp Cys

(3S)-3-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C13H21N5O8S (407.11107860000004)


   

Fmoc-(R)-3-Amino-4-(2-thienyl)-butyric acid

Fmoc-(R)-3-Amino-4-(2-thienyl)-butyric acid

C23H21NO4S (407.1191226000001)


   

Fmoc-(S)-3-Amino-4-(3-thienyl)-butyric acid

Fmoc-(S)-3-Amino-4-(3-thienyl)-butyric acid

C23H21NO4S (407.1191226000001)


   

N,N,N,N-BIS(TETRAMETHYLENE)-O-(1,2-DIHYDRO-2-OXO-1-PYRIDYL)URONIUM HEXAFLUOROPHOSPHATE

N,N,N,N-BIS(TETRAMETHYLENE)-O-(1,2-DIHYDRO-2-OXO-1-PYRIDYL)URONIUM HEXAFLUOROPHOSPHATE

C14H20F6N3O2P (407.1197262)


   

berberine chloride dihydrate

berberine chloride dihydrate

C20H22ClNO6 (407.11355820000006)


   

TRIMETHYL [2,2:6,2-TERPYRIDINE]-4,4,4-TRICARBOXYLATE

TRIMETHYL [2,2:6,2-TERPYRIDINE]-4,4,4-TRICARBOXYLATE

C21H17N3O6 (407.1117302)


   

Fmoc-(R)-3-Amino-4-(3-thienyl)-butyric acid

Fmoc-(R)-3-Amino-4-(3-thienyl)-butyric acid

C23H21NO4S (407.1191226000001)


   

Peraclopone

Peraclopone

C20H23Cl2N3O2 (407.1167238)


   

Fmoc-(S)-3-Amino-4-(2-thienyl)-butyric acid

Fmoc-(S)-3-Amino-4-(2-thienyl)-butyric acid

C23H21NO4S (407.1191226000001)


   

C16H15F6N5O

C16H15F6N5O (407.11807319999997)


   

5-Hydroxy-clethodiM Sulfone

5-Hydroxy-clethodiM Sulfone

C17H26ClNO6S (407.11692860000005)


   

sinapine bisulphate

sinapine bisulphate

C16H24NO5.HSO4 (407.124996)


   

7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrazine

7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrazine

C16H15F6N5O (407.11807319999997)


   

N-(3-chlorophenyl)-2-[1-(3,4-dimethylphenyl)-4-oxo-5-pyrazolo[3,4-d]pyrimidinyl]acetamide

N-(3-chlorophenyl)-2-[1-(3,4-dimethylphenyl)-4-oxo-5-pyrazolo[3,4-d]pyrimidinyl]acetamide

C21H18ClN5O2 (407.1148958)


   

8'-(Pyridin-2-ylmethoxy)spiro[2,4-dioxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene-3,4'-naphthalene]-1'-one

5-[(pyridin-2-yl)methoxy]-4H-2,4-dioxaspiro[naphthalene-1,3-tricyclo[7.3.1.0^{5,13}]tridecane]-1(12),5,7,9(13),10-pentaen-4-one

C26H17NO4 (407.11575220000003)


   

N-[5-[[2-(4-methylanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-2-(4-morpholinyl)acetamide

N-[5-[[2-(4-methylanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-2-(4-morpholinyl)acetamide

C17H21N5O3S2 (407.10857560000005)


   

1-(3,4-Dichlorophenyl)-3-[1-(4-morpholinyl)-1-phenylpropan-2-yl]urea

1-(3,4-Dichlorophenyl)-3-[1-(4-morpholinyl)-1-phenylpropan-2-yl]urea

C20H23Cl2N3O2 (407.1167238)


   

Cyclohexylmethyl-[3-[1-(3,4-dichlorophenyl)ethylamino]-2-hydroxypropyl]phosphinic acid

Cyclohexylmethyl-[3-[1-(3,4-dichlorophenyl)ethylamino]-2-hydroxypropyl]phosphinic acid

C18H28Cl2NO3P (407.1183768)


   

TP003

TP003

C23H16F3N3O (407.1245402)


TP003 is a non-selective benzodiazepine site agonist with EC50s of 20.3, 10.6, 3.24, 5.64 nM for α1β2γ2, α2β3γ2, α3β3γ2, α5β2γ2, respectively. TP003 induces anxiolysis via α2GABAA receptors[1].

   

1(P-hydroxyphenyl)-1-(O-acetyl)prop-2-ene

NA

C18H21N3O6S (407.11510060000006)


{"Ingredient_id": "HBIN002991","Ingredient_name": "1(P-hydroxyphenyl)-1-(O-acetyl)prop-2-ene","Alias": "NA","Ingredient_formula": "C18H21N3O6S","Ingredient_Smile": "CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33452","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C19H21NO9 (407.1216256)


   

(2s,3s,4s,5s,6r)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4s,5s,6r)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C19H21NO9 (407.1216256)


   

(2s,3r,4s,5s,6r)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C19H21NO9 (407.1216256)


   

5,6-dimethoxy-4,7-bis(4-methoxyphenyl)-1,3-benzothiazole

5,6-dimethoxy-4,7-bis(4-methoxyphenyl)-1,3-benzothiazole

C23H21NO4S (407.1191226000001)